More on lly
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1207.27 |
|
|||
| Open | $1194.01 | ||||
| 52 Wk High | $88.16 | ||||
| 52 Wk Low | $67.88 | ||||
| Day High | $1199.00 | ||||
| Day Low | $1171.20 | ||||
| P/E | 273.19 | ||||
| EPS | $4.32 | ||||
| Volume | 2,273,559 | ||||
- Morgan Stanley analysts visit National Resilience facility in Ohio, clients include LLY and AZN
- The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
- Lilly files six lawsuits over illegal sales of unapproved retatrutide
- Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
- Form 4 ELI LILLY & Co For: Aug 10 Filed by: Zakrowski Donald A
- Eli Lilly selects Veeva Vault CRM for global deployment
- BofA raises obesity market forecast on Lilly stock international strength
- Form 144 ELI LILLY & Co Filed by: Zakrowski Donald A
- Form 4 ELI LILLY & Co For: Aug 07 Filed by: Hakim Anat
- Eli Lilly's weight-loss pill secures first European nod in Britain
Entities mentioned with LLY
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Dividend | View Related Stories »
- Show More...
